Array Biopharma (ARRY) Stock: Heading Up On Earnings And Clinical Data

Array Biopharma Inc (NASDAQ: ARRY) is having a relatively strong start to the trading session in the pre-market hours this morning, and for good reason. The company not only reported its earnings for the second quarter, it also reported clinical data that seems to be overwhelmingly positive. Today, we’ll talk about the earnings, the data, what … Read more

Array Biopharma (ARRY) Stock: Why It’s Soaring & Will It Continue?

Array Biopharma Inc (NASDAAQ: ARRY) Array Biopharma had an incredible day in the market yesterday. That movement is being followed up by strong gains in the market today. All of this is happening for good reason. Yesterday, top-line results from a key clinical trial were released that proved to be overwhelmingly positive. Today, we’ll talk … Read more

Array Biopharma (ARRY) Declines: Should You Be Concerned

Array Biopharma Inc (NASDAQ: ARRY) Array Biopharma started the week off strong before declining through yesterday’s trading session and continuing those declines today. Now the question is, “Should investors be concerned about ARRY declines?” Today, I’ll do my best to answer that question. Why ARRY Skyrocketed Before we get into why Array Biopharma is declining … Read more